Home
Conditions
Neoplasms, Plasma Cell

Clinical trial condition

Neoplasms, Plasma Cell

Explore clinical trials studying Neoplasms, Plasma Cell. Study availability and eligibility vary by location and protocol.

2,604 public trials 547 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Plasma Cell trial results

Recruiting

A Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors

NCT06783816

Conditions: Acute Lymphocytic Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations: Shanxi Bethune Hospital Taiyuan, Shanxi, China

View Trial Details

Recruiting

A Trial of Selinexor, Ruxolitinib and Methylprednisolone

NCT06225310

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Berenson Cancer Center West Hollywood, California, United States

View Trial Details

Recruiting

A Study of Venetoclax in Combination With Isatuximab and Dexamethasone for Relapsed/Refractory Multiple Myeloma

NCT06115135

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations: Berenson Cancer Center West Hollywood, California, United States

Nebraska Cancer Specialists Omaha, Nebraska, United States

View Trial Details

Recruiting

A Machine Learning Approach to Connect Multiple Myeloma Complexity to Early Disease Recurrence

NCT06767254

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Istituto Romagnolo per lo Studio dei Tumori "Dino Amadori" - IRST IRCCS Meldola, Forlì-Cesena, Italy

IRCCS Azienda Ospedaliero-Universitaria di Bologna Bologna, Italy

ARNAS "G. Brotzu" di Cagliari Cagliari, Italy

Azienda Ospedaliera Universitaria Federico II Naples, Italy

View Trial Details

Recruiting

Safety and Efficacy of Anti-BCMA/FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM)

NCT06759181

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Xuzhou Xuzhou, China

View Trial Details

Recruiting

Safety and Efficacy of Fourth-Generation CAR-T in the Treatment of Hematologic Malignancies

NCT06758713

Conditions: B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: The Third Affiliated Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Bortezomib, Pomalidomide, Dexamethasone for Systemic AL Amyloidosis

NCT06342466

Conditions: Amyloidosis, Immune System Diseases, Immunoglobulin Light-chain Amyloidosis, +10 more
Locations: Peking University People's Hospital Beijing, Beijing Municipality, China

View Trial Details

Recruiting

Characteristics and Clinical Significance of Gut Microbiota in Patients With Monoclonal Gammopathy

NCT06690593

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +17 more
Locations: Zhujiang Hospital of Southern Medical University Guanzhou, Guangdong, China

View Trial Details

Recruiting

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

NCT06082284

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations: Zhujiang Hospital of Southern Medical University Guangzhou, Guangdong, China

View Trial Details

Recruiting

Study Comparing Therapy for Advanced Relapsed/Refractory Multiple Myeloma With and Without Dexamethasone

NCT06561854

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Disease Attributes, +17 more
Locations: Service d'hématologie clinique et thérapie cellulaire, Saint-Antoine Hospital Paris, France

View Trial Details

Neoplasms, Plasma Cell

Neoplasms, Plasma Cell trial results

Related conditions